AR023726A1 - Terapia con gch para el tratamiento del cancer de mama - Google Patents
Terapia con gch para el tratamiento del cancer de mamaInfo
- Publication number
- AR023726A1 AR023726A1 ARP990106407A ARP990106407A AR023726A1 AR 023726 A1 AR023726 A1 AR 023726A1 AR P990106407 A ARP990106407 A AR P990106407A AR P990106407 A ARP990106407 A AR P990106407A AR 023726 A1 AR023726 A1 AR 023726A1
- Authority
- AR
- Argentina
- Prior art keywords
- gch
- treatment
- cancer
- therapy
- mama
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invencion se refiere al campo de la terapia contra el cáncer. Más particularmente, la invencion se refiere al tratamiento de tumores mamarios, lostumores mamarios clínicamente manifiestos (cáncer de mama), y los tumores de mama metastásicos mediante la administracion de Gonadotropina corionica humana(GCh). El tratamiento preferentemente consiste en la administracion de GCh junto con un antiestrogeno y/o Interferon Tipo I.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98123817A EP1013281A1 (en) | 1998-12-15 | 1998-12-15 | hCG therapy for the treatment of breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023726A1 true AR023726A1 (es) | 2002-09-04 |
Family
ID=8233138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990106407A AR023726A1 (es) | 1998-12-15 | 1999-12-15 | Terapia con gch para el tratamiento del cancer de mama |
Country Status (16)
Country | Link |
---|---|
US (1) | US7183251B1 (es) |
EP (2) | EP1013281A1 (es) |
JP (1) | JP2003523311A (es) |
AR (1) | AR023726A1 (es) |
AT (1) | ATE353664T1 (es) |
AU (1) | AU781495B2 (es) |
BR (1) | BR9916221A (es) |
CA (1) | CA2351726A1 (es) |
CY (1) | CY1106525T1 (es) |
DE (1) | DE69935156T2 (es) |
DK (1) | DK1140147T3 (es) |
ES (1) | ES2277461T3 (es) |
IL (2) | IL143671A0 (es) |
PT (1) | PT1140147E (es) |
SI (1) | SI1140147T1 (es) |
WO (1) | WO2000035469A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008515818A (ja) * | 2004-10-07 | 2008-05-15 | ステム セル セラピューティクス コーポレイション | 妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激 |
US8968210B2 (en) * | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0160699B1 (en) | 1983-11-02 | 1992-08-12 | Applied Research Systems Ars Holding N.V. | Production of heterodimeric human fertlity hormones |
US5677275A (en) | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
US5700781A (en) | 1994-10-04 | 1997-12-23 | Harris; Pamela Jo | Method for treating Kaposi's sarcoma and HIV infections |
US5997871A (en) * | 1996-06-24 | 1999-12-07 | University Of Maryland Biotechnology Insitute | Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
-
1998
- 1998-12-15 EP EP98123817A patent/EP1013281A1/en not_active Withdrawn
-
1999
- 1999-12-15 AU AU23631/00A patent/AU781495B2/en not_active Ceased
- 1999-12-15 EP EP99967331A patent/EP1140147B1/en not_active Expired - Lifetime
- 1999-12-15 SI SI9930954T patent/SI1140147T1/sl unknown
- 1999-12-15 WO PCT/US1999/029795 patent/WO2000035469A2/en active IP Right Grant
- 1999-12-15 JP JP2000587788A patent/JP2003523311A/ja active Pending
- 1999-12-15 US US09/868,196 patent/US7183251B1/en not_active Expired - Lifetime
- 1999-12-15 PT PT99967331T patent/PT1140147E/pt unknown
- 1999-12-15 DK DK99967331T patent/DK1140147T3/da active
- 1999-12-15 BR BR9916221-0A patent/BR9916221A/pt not_active Application Discontinuation
- 1999-12-15 AT AT99967331T patent/ATE353664T1/de active
- 1999-12-15 CA CA002351726A patent/CA2351726A1/en not_active Abandoned
- 1999-12-15 AR ARP990106407A patent/AR023726A1/es unknown
- 1999-12-15 IL IL14367199A patent/IL143671A0/xx unknown
- 1999-12-15 ES ES99967331T patent/ES2277461T3/es not_active Expired - Lifetime
- 1999-12-15 DE DE69935156T patent/DE69935156T2/de not_active Expired - Lifetime
-
2001
- 2001-06-11 IL IL143671A patent/IL143671A/en not_active IP Right Cessation
-
2007
- 2007-04-12 CY CY20071100514T patent/CY1106525T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000035469A2 (en) | 2000-06-22 |
PT1140147E (pt) | 2007-03-30 |
CY1106525T1 (el) | 2012-01-25 |
WO2000035469A3 (en) | 2000-09-14 |
AU781495B2 (en) | 2005-05-26 |
JP2003523311A (ja) | 2003-08-05 |
DE69935156T2 (de) | 2007-11-22 |
IL143671A (en) | 2009-08-03 |
EP1140147A2 (en) | 2001-10-10 |
WO2000035469A9 (en) | 2001-03-22 |
BR9916221A (pt) | 2001-09-11 |
EP1013281A1 (en) | 2000-06-28 |
EP1140147B1 (en) | 2007-02-14 |
CA2351726A1 (en) | 2000-06-22 |
IL143671A0 (en) | 2002-04-21 |
ATE353664T1 (de) | 2007-03-15 |
ES2277461T3 (es) | 2007-07-01 |
AU2363100A (en) | 2000-07-03 |
SI1140147T1 (sl) | 2007-06-30 |
DK1140147T3 (da) | 2007-03-26 |
US7183251B1 (en) | 2007-02-27 |
DE69935156D1 (de) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8588601A1 (es) | Administracion combinada de una indolinona junto a un agente quimioterapeutico para el tratamiento de enfermedades de proliferacion celular | |
EA200800268A1 (ru) | КОМБИНИРОВАННАЯ ТЕРАПИЯ АНТИТЕЛОМ ПРОТИВ CTLA-4 И СОДЕРЖАЩИМ CpG-МОТИВ СИНТЕТИЧЕСКИМ ОЛИГОДЕЗОКСИНУКЛЕОТИДОМ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ | |
TR200003879T2 (tr) | İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@ | |
DK1556058T3 (da) | Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi | |
WO2002080754A3 (en) | Methods for using annexin for detecting cell death in vivo and treating associated conditions | |
BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
DK1228208T3 (da) | 36P6D5: udskilt tumorantigen | |
IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
BG101290A (en) | New promedicaments for the therapy of tumours and inflammatory diseases | |
PT1242060E (pt) | Tratamento da doenca metastatica | |
HK1175846A1 (en) | Cytotoxicity mediation of cells evidencing surface expression of cd44 cd44 | |
BRPI0415525A (pt) | derivados de imidazola e seu uso como agentes farmacêuticos | |
IL146125A0 (en) | Novel quinones as disease therapies | |
BR9808509A (pt) | Composições e métodos para o tratamento e diagnóstico do câncer de mama | |
ATE406155T1 (de) | Triptolid-prodrugs zur krebstherapie | |
WO2004096159A3 (en) | Saposin c-dops: a novel anti-tumor agent | |
BRPI0407611A (pt) | agente anti-cáncer compreendendo proteìna lk8 como um ingrediente ativo | |
AR023726A1 (es) | Terapia con gch para el tratamiento del cancer de mama | |
ES2191784T3 (es) | Vacunas de tumores de citocinas paracrinas alogenicas. | |
ES2073277T3 (es) | Sustancias de naturaleza polipeptida utiles en la terapia humana. | |
SV2002000179A (es) | Proceso para la preparacion de un compuesto para reducir el riesgo del cancer ref.x-13527-el | |
BR0111024A (pt) | Composições e métodos para a terapia e diagnóstico de câncer de mama | |
BR9808263A (pt) | Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto. | |
ATE306255T1 (de) | 19-nor-vitamin d3 derivate mit calciumspiegel erhöhender wirkung | |
DE60206599D1 (de) | Biotin-derivate und ihre konjugaten mit chelatierungsmitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |